Petros Pharmaceuticals, Inc. terminated its relationship with Marcum LLP as its independent accounting firm on April 5, 2025, and engaged CBIZ CPAs for the fiscal year ending December 31, 2025. Marcum's reports for 2023 and 2024 included a note about substantial doubt regarding the company's ability to continue as a going concern.